LISTSERV 16.0 - PARKINSN Archives

Subscriber's Corner

Email Lists

PARKINSN Archives

PARKINSN@LISTSERV.UTORONTO.CA

View:

Message:

[

First

Last

]

By Topic:

[

First

Last

]

By Author:

[

First

Last

]

Font:

Monospaced Font

		LISTSERV Archives
		PARKINSN Home
		PARKINSN October 1998, Week 5

Subject:

CSRINDX NOV 98 Part 1 of 3

From:

"J. R. Bruman" <[log in to unmask]>

Reply-To:

[log in to unmask]

Date:

Sat, 31 Oct 1998 15:47:34 -0800

Content-Type:

text/plain

Parts/Attachments:

text/plain (310 lines)

I N D E X , C U R R E N T

NOTICE: This Index to past with each new monthly posting cumulative, you may safely are posted for the benefit status of PD research. For what this is all about, please
     SUBJECT        Acetazolamide (Diamox) Movement Disorders      " Acetylcholine agonist Annals Acetyl-L Carnitine Neur Activa (Medtronics DBS)Neur ADHD, and dopamine Lancet Agonists, action Neur      "      "      "      " ,      "      "      " , Albuterol Neur Alpha-synuclein Science News      "      "      "      " Alternative medicine British Medical J Alzheimer's and PD Ann Neur      " Amantadine (Symmetrel) Neur      "      " summary      " withdrawal Aminophylline Br J Anosmia Arch Neur Anticipation Neur Antioxidants, dietary Mov Disord Apolipoprotein E J Neur      "      "      " Apomorphine, PD effcts J Neur      "      "      "      "      "      " as a test      "      "      "      "      ", and libido      ",      ",      ", Apoptosis Ann Neur      "      "      "      "      "      " , caspase      "      " , review Appetite increase Neur Aptiganel Clin Neuropharm Artane, withdrawal Ann Neur Assisted suicide Neur Attention deficit Clin Neuropharm Autonomous deficit Neur Autosomal-d, dementia Ann Neur Axial motor control J Neur BAM-1110 Clin Neuropharm Behavioral treatment Mov Disord Biochemical aspects Neur Blink reflex, and PD J Neurosci   " rate Botulinum toxin Neur      "      "      " Boxers, parkinsonism J Neur Brain injury Neur Bradykinesia Brain      "      "      "      " Breast milk Neur Bromocryptine J Neur      "      " Bruxism Mov Disord Cabergoline Arch Neur      "      "      "      " Calcium deficiency Mov Disord Carbidopa, stability Mov Disord Caregivers, effect on Mov Disord Carnitine, Acetyl-L Neur Cerebellum, in ET Neur      "      " Cerebrospinal fluid J Neur      " Chocolate and red wine Lancet Cinnarizine Mov Disord      " Cisapride Mov Disord Citalopram interaction Clin Neuropharm Clonidine Lancet Clozapine (Clozaril) Lancet      "      "      "      "      "      "      "      " for tremor      " "      " lit. review Cocaine, effect J Neurosci Coenzyme Q10 Neur Cognitive decline J Neur      "      "      "      "      "      "      "      " Color discrimination Neur       " Complex I (enzyme) Ann Neur       "       " COMT, action Neur   " inhibitors   " "   " "   " " Constipation Lancet      "      "      " Coordination Brain      "      "      "      "      " Cost of PD care Mov Disord DATATOP Arch Neur      "      "      "      " Degeneration, pattern Brain Deep-brain stimulation Arch Neur      "      "      "      "      "      "      "      "      "      "      " for ET      "      "      "      "      "      "      "      "      "      "      "      " Dementia, Downs and J Neur      "      "      "      " , incidence      " ,      " ,      " ,      " , PD vs AD      "      " ,      " ,      "      " Dependency Mov Disord Depression Arch Neur      "      "      "      "      " Desynchronization Mov Disord Dextromethorphan Neur DHEA Lancet Diagnosis, clinical Brain      " ,      " ,      " ,      " ,      " , MRI Dimethyl Selegiline J Neurochem DLBD J Neur   " ,FD-PET diagnosis Neur Domperidone Mov Disord Dopamine agonists Neur      "      " neurons      "      "      "      "      "      "      "      "      "      "      "      "      "      " Down's syndrome Neur Driving ability JAMA      "      " Drug industry hype Time      "      " Drug strategy Neur " " " " " therapy, general Neur " " , " " " , history Neur Dyskinesia Neur      "      "      "      ",      " ,      " ,      " ,      " ,      " ,      " ,      " , Dystonia and pallidot- J Neur      "      "      "      " Eldepryl (selegiline) Ann Neur Electroconvulsive (PSP)Neur      " Encephalitis, childhoodJ Neur      " Entacapone (Comtan) J Neur      "      "      "      " Enteric nervous system New England J Med Essential tremor, VIM Neur      "      "      "      "      "      "      "      "      "      "      "      "      "      "      "      "      "      "
--
J. R. Bruman (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013 S C I E N C E R E V I E W S
              (Revised November 1998)
Current Science Reviews is revised
of the CSR. As the revisions are
discard any earlier Index. The CSRs
of those listmembers interested in the
a slightly more detailed explanation of
see the Introduction dated April 98.
SOURCE JOURNAL JOURNAL REF. CSR
                                                        DATE
1993;8:240-241 Nov 95
Neurology 1995;45:458-460 Jun 96
of Neurology 1998;43:311-317 Apr 98
1996;47:705-711 Oct 96
1998;50:ad insert Jun 98
27 Jul 1996:255 Sep 96
1995;45,S3:S5 May 95
Neur 1997;49:421-426 Oct 97
Mov Disord 1998;13:768-774 Nov 98
, D1 vs D2 Archives of Neurolo 1997;54(8)Aug Oct 97
" Ann Neur 1998;43:202-203 Mar 98
Clin Neuropharmacol 1998;21:35-40 Apr 98
, neuroprotect Ann Neur 1998;44:110-119 Aug 98
" Neur 1998;51S2:S10-S12 Sep 98
1994;8:1511-1513 Dec 94
18 Oct 1997;255 Nov 97
Arch Neur 1998;55:1555ff Mar 98
Ann Neur 1998;43:394-397 Apr 98
Ann Neur 1998;44:270-273 Sep 98
J Neur N'surg Psych 1998;64:378-379 Oct 98
17 Aug 1996 Oct 96
1995;37:300-312 Apr 95
" " J Neur N'surg Psych 1996;61:391-387 Nov 96
1996;46:1551-1556 Jul 96
inhibits NMDA Neur 1998;50:1323-1326 Jul 98
Neur 1998;50:1211-1212 Jul 98
Neur 1998;50:1456-1458 Jul 98
Clin Pharmacol 1997;43:119-121 Sep 97
1998;55:84-90 Feb 98
1996;47:1512-1517 Feb 97
1997;12:190-195 May 97
N'surg Psych 1996;61:347-351 Nov 96
J Neur N'surg Psych 1997;63:394-395 Nov 97
Ann Neur 1997;42:655-658 Nov 97
Ann Neur 1998;44:294 Sep 98
N'surg Psych 1994;8:998-1001 Dec 94
, " J Neur N'surg Psych 1996;61:634-637 Aug 96
, " Clin Neuropharm 1997;20:165-167 May 97
, " Clin Neuropharm 1997;20:245-252 Sep 97
, " BMJ 28 Feb 98;641 Mar 98
, " Mov Disord 1998;13:782-787 Nov 98
Mov Disord 1998;13:533-535 Jul 98
, availability Lancet 1995;345:517-518 Apr 95
dosage determ Clin Neuropharm 1998;21:152-158 Jul 98
and erection Mov Disord 1998;13:536-539 Jul 98
and levodopa Clin Neuropharm 1998;21:86-92 Jun 98
Clin Neuropharm 1997;20:140-147 May 97
formulation Mov Disord 1998;13:52-55 Mar 98
pharmacology Clin Neuropharm 1998;21:159-168 Aug 98
self-injection J Neur N'surg Psych 1995;58:681-687 Jul 95
1995;38:839-851 Feb 96
Science News 16 Nov 96:316 Dec 96
Science 21 Feb 97;1081-82 Mar 97
J Neurosci 1997;17:1075-1085 Apr 97
J Neurosci 1997;17:1397-1405 Apr 97
Mov Disord 1998;13:221-227 May 98
Nature Med 1997;3:954-955 Oct 97
,L-dopa induced Mov Disord 1997;12:17-23 Feb 97
JAMA 28 Jan 98;300-307 Mar 98
1997;49:310-311 Aug 97
1997;20:311-321 Sep 97
1997;41:133 Mar 97
1998;50:596-598 Apr 98
1998;21:108-117 Jun 98
1997;48:662-667 Apr 97
1998;43:768-781 Jul 98
N'surg Psych 1996;61:645-648 Feb 97
1998;21:35-40 Apr 98
1997;12:306-314 Aug 97
1998;51S2:S2-S9 Sep 98
1996;16:7308-7330 Dec 96
J Neur N'surg Psych 1998;64:320-324: May 98
1995;45:822-824 Jun 96
Archives of Neur 1996;53:617-624 Aug 96
J Neur N'surg Psych 1996;61:693 Aug 96
Mov Disord 19997;12:764-766 Nov 97
N'surg Psych 1995;58:688-691 Jul 95
1996;47:1358-1359 Jan 97
1996;119:801-813 Sep 96
Clin Neuropharm 1997;20:402-408 Dec 97
Brain 1998;121:505-514 Apr 98
Brain 1998;121:755-766 Jun 98
and pallidotomy Neur 1998:51:796-803 Oct 98
1998;50:1920-1921 Aug 98
N'surg Psych 1994;8:903-910 Dec 94
Lancet 20 Jan 1996:196 Mar 96
plus levodopa Clin Neuropharm 1997;20;67-76 May 97
1997;12:73-78 Feb 97
1994;51:1236-1241 Jan 95
Lancet 11 Nov 1995:1290 Dec 95
Neur 1996;46:1062-1065 Jun 96
Neur 1997;48:363-368 Mar 97
Clin Neuropharm 1997;20:455-465 Dec 97
1997:12:612-613 Sep 97
1997;12:608-610 Sep 97
1998;13:20-28 Mar 98
1996:47:705-711 Oct 96
1996;46:1200-1205 Jun 96
" Ann Neur 1996;39:650-658 Jun 96
,cognition in Science 28 Mar 97:1940-43 May 97
N'surg Psych 1997;63:754-758 Feb 98
Mov Disord 1998;13:70-77 May 98
21 Sep 96:834 Oct 96
1997;12:107-110 Feb 97
Mov Disord 1998;13:453-456 Jul 98
1997;12:423-425 Aug 97
1997;20:419-433 May 98
28 Jun 97:1877-81 Aug 97
1995;345:517-518 Apr 95
Neur 1995;45:432-434 Apr 95
BMJ 16 Nov 1996:1313 Jan 97
J Neur N'surg Psych 1997;63:120 Sep 97
Clin Neuropharm 1997;20:201-209 Sep 97
Mov Disord 1998;13:377-382 Jul 98
for dyskinesia Neur 1997;48:658-662 Apr 97
relieves "off" Mov Disord 1997;12:159-166 May 97
Neur 1997;48:1077-1091 May 97
" Neur 1997;49:1587-1590 Feb 98
Mov Disord 1997;12:483-496 Sep 97
1996;16:7670-7677 Jan 97
1998;50:793-795 Apr 98
N'surg Psych 1995;58:51-55 Feb 95
J Neur N'surg Psych 1996;60:564-571 Jun 96
J Neurosci 1996;16:7768-7775 Jan 97
Brain 1996;119:2121-32 Mar 97
Neur 1997;48:546-547 Mar 97
Arch Neur 1997;54:296-302 Apr 97
Arch Neur 1997;54:947-950 Sep 97
Arch Neur 1998;55:372-378 Apr 98
J Neur N'surg Psych 1998;65:155-163 Sep 98
1995;45:386-387 Mar 95
Brain 1995;118:771-778 Jul 95
1996;40:663-671 Nov 96
Mov Disord 1997;12:3-8 Feb 97
Mov Disord 1998;13;11-15 Mar 98
1998;50S5:S1-S2 Aug 98
Lancet 25 Apr 98:1221-22 Jun 98
Neur 1998;50S5:S3-S14 Aug 98
Neur 1998;50S5:S26-S30 Aug 98
Neur 1998;50S6:S27-S32 Aug 98
1995;346:861-864 Nov 95
Mov Disord 1997;12:423-425 Aug 97
Mov Disord 1997;12:764-766 Nov 97
psyllium for Mov Disord 1997;12:946-951 Jan 98
1998;121:1771-84 Oct 98
J Neur N'surg Psych 1998;65:328-337 Oct 98
, 2-limb Mov Disord 1997;12:958-968 Jan 98
, " Brain 1998;121:725-742 Jun 98
, " Brain 1998;121:743-753 Jun 98
, " Mov Disord 1998;13:422-427 Sep 98
1998;13:249-254 May 98
1995;52:565-570 Nov 95
Ann Neur 1996;39:29-36 Mar 96
Ann Neur 1996;40:946-949 Mar 97
, end point in Mov Disord 1997;12:183-189 May 97
, mortality Ann Neur 1998;43:318-325 Apr 98
1997;120:2197-2206Feb 98
1996;53:898-903 Oct 96
Neur 1996;46:1150-1153 Jun 96
Neur 1997;49:259-253 Aug 97
J Neurosurg 1997;87:491-498 Nov 97
Mov Disord 1997;12:727-737 Nov 97
Neur 1997;49:1570-1576 Feb 98
Neur 1998;51:850-855 Oct 98
best sites Ann Neur 1997;42:283-29 Oct 97
" Ann Neur 1998;43:180-192 Mar 98
" Brain 1998;121:451-457 Apr 98
" STN NEJM 1998;16:1105-1111 Nov 98
Mov Disord 1997;12:337-341 Aug 98
" Mov Disord 1998;13:690-692 Sep 98
" or PD Ann Neur 1997;42:292-299 Oct 97
" " Mov Disord 1998;13:78-83 Mar 98
, Medtronics Neur 1998;50:ad Jun 98
, parameters Mov Disord 1998;13:648-652 Sep 98
, technique Ann Neur 1998;44:622-628 Nov 98
, thalamic Neur 1998;51:1063-1069 Nov 98
, voice tremor Neur 1998;50:796-789 Apr 98
vs pallidotomy Nat Med 1997;3:671-674 Jul 97
" Nat Med 1997;3:602-603 Jul 97
" J Neurosurg 1997;87:700-705 Dec 97
" Lancet 25 Oct 1997:1224 Dec 97
N'surg Psych 1997;62:289 Apr 97
, estrogen and Neur 1998;50:1141-1143 Jun 98
,frontotemporal Ann Neur 1997;41:706-715 Jul 97
" Ann Neur 1998;42:794-798 Mar 98
Neur 1995;45:705-708 Jun 96
" Arch Neur 1996;53:538-542 Jul 96
" Neur 1997;49:1570-1576 Feb 98
" Neur 1998;50S6:S33-S38 Aug 98
Neur 1995;45:1025 Jul 95
, preclinical Neur 1995;45:1691-1696 Jan 96
" J Neur N'surg Psych 1998;64:178-183 Apr 98
" Arch Neur 1998;55:674-680 Jun 98
, tacrine for J Neur N'surg Psych 1996;61:324-325 Oct 96
, wine prevents BMJ 5 Apr 97:997 May 97
1997;12:910-915 Jan 98
1996;53:175-179 Mar 96
Neur 1996;47:1148-1152 Jan 97
Arch Neur 1997;54:625-630 Jun 97
J Neur N'surg Psych 1997;63:590-596 Jan 98
, incidence Mov Disord 1998;13:29-33 Mar 98
in DLBD Neur 1998;50:573 Mar 98
1998;13:653-660 Sep 98
1998;51:203-206 Aug 98
18 Jul 1998:208 Sep 98
1997;120:75-90 Apr 97
" J Neur N'surg Psych 1997;62:245-252 Apr 97
" Clin Neuropharm 1997;20:239-244 Sep 97
" Brain 1997;120:1877-83 Dec 97
" Arch Neur 1998;55:372-378 Apr 98
Brain 1997;120:1541-52 Nov 97
1997;68:434-436 Aug 97
N'surg Psych 1996;60:531-538 Jun 96
1996;47:462-466 Sep 96
1997;12:952-957 Jan 98
1998:50S6:S23-S26 Aug 98
, exogenous Neur 1998;50S5:S17-S25 Aug 98
Mov Disord 1997;12:885-897 Jan 98
, non-PD use BMJ 8 Mar 97:689-690 Apr 97
receptors J Neurosci 1996;16:6579-6591 Nov 96
" Mov Disord 1997;12:33-38 Feb 97
" Neur 1997;48:1589-1593 Jul 97
" Mov Disord 1998;13:788-797 Nov 98
storage sites J Neurosci 1996;16:4135-4145 Nov 96
transporter Science 16 Feb 1996:909 Mar 96
" J Neurosci 1997;17:960-974 Apr 97
" Neur 1997;48:1578-1583 Jul 97
" Mov Disord 1997;12:629-633 Nov 97
" Mov Disord 1997;12;760-763 Nov 97
" Neur 1997;49:1577-1579 Feb 98
" Ann Neur 1998;43:555-560 Jun 98
" J Neur N'surg Psych 1998;65:164-169 Sep 98
1994;44:2419 Feb 95
17 Jan 1996:182 Feb 96
J Neur N'surg Psych 1996;61:621-627 Aug 96
J Neur N'surg Psych 1998;64:325-330 May 98
21 Oct 1996:92 Nov 96
Ann Neur 1997;42:Aug Sep 97
Arch Neur 1997;54:1508-1509 Jan 98
1997;49S1:S2-S62 Aug 97
Clin Neuropharm 1998;17S2:14-18 May 98
Neur 1998;50S6:S18-S22 Aug 98
1998;50S6:S1-S48 Aug 98
Neur 1998;50S6:S11-S14 Aug 98
1998;50S6:S2-S10 Aug 98
1997;48:369-372 Mar 97
, amantadine Neur 1998;50:1323-1326 Jul 98
, apomorphine BMJ 18 Feb 98;641 Mar 98
, clozapine for Neur 1997;48:658-682 Apr 97
L-dopa-induced Mov Disord 1997;12:148-158 May 97
" (LID) Neur 1997;49:717-723 Oct 97
" " Ann Neur 1998;42:720-726 Mar 98
" " Brain 1998;121:50-75 Mar 98
" " Neur 1998;50:573 Mar 98
" " Brain 1998;121:527-533 Apr 98
" " Mov Disord 1998;13:731-734 Sep 98
" " Mov Disord 1998;13:798-802 Nov 98
N'surg Psych 1998;65:604-605 Nov 98
, early-mornin Neur 1998;51:283-285 Sep 98
etiology J Neur N'surg Psych 1998;65:436-445 Nov 98
, hereditary Neur 1998;50:517-519 Mar 98
, rapid-onset Ann Neur 1998;43:521-526 Jun 98
1994;36;759-764 Dec 94
1996;46:1284-1286 Jun 96
(PD) J Neur N'surg Psych 1996;61:693-694 Aug 96
N'surg Psych 1996;60:589 Jun 96
" J Neur N'surg Psych 1998;64:5 Feb 98
N'surg Psych 1996;60:36-40 Feb 96
Mov Disord 1997;12:497-505 Sep 97
Ann Neur 1997;42:747-755 Dec 97
Mov Disord 1997;12:935-945 Jan 98
Lancet 25 Apr 98:1221-22 Jun 98
25 Apr 96:1106-15 Jun 96
1996;46:1150-1153 Jun 96
,aminophylline Br J Clin Pharmacol 1997;43:119-121 Sep 97
, and PD Neur 1995;45:645-648 Jun 96
, botulinum Neur 1995;45:822-824 Jun 96
, components Mov Disord 1998;13:803-808 Nov 98
, and DBS Mov Disord 1997;12:337-341 Aug 97
, diagnosis Mov Disord 1997;12:973-976 Jan 98
, " Mov Disord 1997;12:969-972 Jan 98
, " Mov Disord 1998;13:287-293 May 98
, etiology Neur 1996;46:1200-1205 Jun 96
" Neur 1996;47:264-265 Sep 96
" Ann Neur 1997;41:32-40 Mar 97
" J Neurol Sci 1997;149:195-196 Aug 97
" Neuroepidemiology 1997;16:124-133 Sep 97
" Arch Neur 1997;54:289-254 Sep 97
" Arch Neur 1997;54:197-200 Sep 97
" J Neur N'surg Psych 1998;64:273-276 Apr 98
" Neur 1998;50:1351-1357 Jul 98
, gene for Mov Disord 1997;12:859-864 Jan 98

Top of Message | Previous Page | Permalink

Search Archives

Advanced Options

Options

		Log In
		Get Password

		Search Archives

		Subscribe or Unsubscribe

Archives

ATOM RSS1 RSS2

LISTSERV.UTORONTO.CA